Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease

Suzette J Bielinski, Cecilia Berardi, Paul A. Decker, Nicholas Larson, Elizabeth J. Bell, James S. Pankow, Michele M. Sale, Weihong Tang, Naomi Q. Hanson, Christina L. Wassel, Mariza De Andrade, Matthew J. Budoff, Joseph F. Polak, Hugues Sicotte, Michael Y. Tsai

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective To determine if hepatocyte growth factor (HGF), a promising biomarker of coronary heart disease (CHD) given its release into circulation in response to endothelial damage, is associated with subclinical and clinical CHD in a racial/ethnic diverse population. Methods HGF was measured in 6738 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Highest mean HGF values (pg/mL) were observed in Hispanic, followed by African, non-Hispanic white, then Chinese Americans. Results In all races/ethnicities, HGF levels were associated with older age, higher systolic blood pressure (SBP) and body mass index, lower high-density lipoprotein, diabetes and current smoking. In fully adjusted models, each SD higher HGF was associated with an average increase in coronary artery calcium (CAC) of 55 Agatston units for non-Hispanic whites (p<0.001) and 51 Agatston units for African-Americans (p=0.007) but was not in the other race/ethnic groups (interaction p=0.02). There were 529 incident CHD events, and CHD risk was 41% higher in African (p<0.001), 17% in non-Hispanic white (p=0.026) and Chinese (p=0.36), and 6% in Hispanic Americans (p=0.56) per SD increase in HGF. Conclusion In a large and diverse population-based cohort, we report that HGF is associated with subclinical and incident CHD. We demonstrate evidence of racial/ethnic heterogeneity within these associations, as the results are most compelling in African-Americans and non-Hispanic white Americans. We provide evidence that HGF is a biomarker of atherosclerotic disease that is independent of traditional risk factors.

Original languageEnglish (US)
Pages (from-to)1185-1193
Number of pages9
JournalHeart
Volume103
Issue number15
DOIs
StatePublished - Aug 1 2017

Fingerprint

Hepatocyte Growth Factor
Coronary Disease
Biomarkers
Hispanic Americans
African Americans
Asian Americans
HDL Lipoproteins
Ethnic Groups
Population
Atherosclerosis
Coronary Vessels
Body Mass Index
Smoking
Blood Pressure
Hypertension
Calcium

Keywords

  • atherosclerosis
  • coronary disease
  • epidemiology
  • risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease. / Bielinski, Suzette J; Berardi, Cecilia; Decker, Paul A.; Larson, Nicholas; Bell, Elizabeth J.; Pankow, James S.; Sale, Michele M.; Tang, Weihong; Hanson, Naomi Q.; Wassel, Christina L.; De Andrade, Mariza; Budoff, Matthew J.; Polak, Joseph F.; Sicotte, Hugues; Tsai, Michael Y.

In: Heart, Vol. 103, No. 15, 01.08.2017, p. 1185-1193.

Research output: Contribution to journalArticle

Bielinski, SJ, Berardi, C, Decker, PA, Larson, N, Bell, EJ, Pankow, JS, Sale, MM, Tang, W, Hanson, NQ, Wassel, CL, De Andrade, M, Budoff, MJ, Polak, JF, Sicotte, H & Tsai, MY 2017, 'Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease', Heart, vol. 103, no. 15, pp. 1185-1193. https://doi.org/10.1136/heartjnl-2016-310450
Bielinski, Suzette J ; Berardi, Cecilia ; Decker, Paul A. ; Larson, Nicholas ; Bell, Elizabeth J. ; Pankow, James S. ; Sale, Michele M. ; Tang, Weihong ; Hanson, Naomi Q. ; Wassel, Christina L. ; De Andrade, Mariza ; Budoff, Matthew J. ; Polak, Joseph F. ; Sicotte, Hugues ; Tsai, Michael Y. / Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease. In: Heart. 2017 ; Vol. 103, No. 15. pp. 1185-1193.
@article{9b825c3b5ce8477fbf35220c4375a2f1,
title = "Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease",
abstract = "Objective To determine if hepatocyte growth factor (HGF), a promising biomarker of coronary heart disease (CHD) given its release into circulation in response to endothelial damage, is associated with subclinical and clinical CHD in a racial/ethnic diverse population. Methods HGF was measured in 6738 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Highest mean HGF values (pg/mL) were observed in Hispanic, followed by African, non-Hispanic white, then Chinese Americans. Results In all races/ethnicities, HGF levels were associated with older age, higher systolic blood pressure (SBP) and body mass index, lower high-density lipoprotein, diabetes and current smoking. In fully adjusted models, each SD higher HGF was associated with an average increase in coronary artery calcium (CAC) of 55 Agatston units for non-Hispanic whites (p<0.001) and 51 Agatston units for African-Americans (p=0.007) but was not in the other race/ethnic groups (interaction p=0.02). There were 529 incident CHD events, and CHD risk was 41{\%} higher in African (p<0.001), 17{\%} in non-Hispanic white (p=0.026) and Chinese (p=0.36), and 6{\%} in Hispanic Americans (p=0.56) per SD increase in HGF. Conclusion In a large and diverse population-based cohort, we report that HGF is associated with subclinical and incident CHD. We demonstrate evidence of racial/ethnic heterogeneity within these associations, as the results are most compelling in African-Americans and non-Hispanic white Americans. We provide evidence that HGF is a biomarker of atherosclerotic disease that is independent of traditional risk factors.",
keywords = "atherosclerosis, coronary disease, epidemiology, risk factors",
author = "Bielinski, {Suzette J} and Cecilia Berardi and Decker, {Paul A.} and Nicholas Larson and Bell, {Elizabeth J.} and Pankow, {James S.} and Sale, {Michele M.} and Weihong Tang and Hanson, {Naomi Q.} and Wassel, {Christina L.} and {De Andrade}, Mariza and Budoff, {Matthew J.} and Polak, {Joseph F.} and Hugues Sicotte and Tsai, {Michael Y.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1136/heartjnl-2016-310450",
language = "English (US)",
volume = "103",
pages = "1185--1193",
journal = "Heart",
issn = "1355-6037",
publisher = "BMJ Publishing Group",
number = "15",

}

TY - JOUR

T1 - Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease

AU - Bielinski, Suzette J

AU - Berardi, Cecilia

AU - Decker, Paul A.

AU - Larson, Nicholas

AU - Bell, Elizabeth J.

AU - Pankow, James S.

AU - Sale, Michele M.

AU - Tang, Weihong

AU - Hanson, Naomi Q.

AU - Wassel, Christina L.

AU - De Andrade, Mariza

AU - Budoff, Matthew J.

AU - Polak, Joseph F.

AU - Sicotte, Hugues

AU - Tsai, Michael Y.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Objective To determine if hepatocyte growth factor (HGF), a promising biomarker of coronary heart disease (CHD) given its release into circulation in response to endothelial damage, is associated with subclinical and clinical CHD in a racial/ethnic diverse population. Methods HGF was measured in 6738 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Highest mean HGF values (pg/mL) were observed in Hispanic, followed by African, non-Hispanic white, then Chinese Americans. Results In all races/ethnicities, HGF levels were associated with older age, higher systolic blood pressure (SBP) and body mass index, lower high-density lipoprotein, diabetes and current smoking. In fully adjusted models, each SD higher HGF was associated with an average increase in coronary artery calcium (CAC) of 55 Agatston units for non-Hispanic whites (p<0.001) and 51 Agatston units for African-Americans (p=0.007) but was not in the other race/ethnic groups (interaction p=0.02). There were 529 incident CHD events, and CHD risk was 41% higher in African (p<0.001), 17% in non-Hispanic white (p=0.026) and Chinese (p=0.36), and 6% in Hispanic Americans (p=0.56) per SD increase in HGF. Conclusion In a large and diverse population-based cohort, we report that HGF is associated with subclinical and incident CHD. We demonstrate evidence of racial/ethnic heterogeneity within these associations, as the results are most compelling in African-Americans and non-Hispanic white Americans. We provide evidence that HGF is a biomarker of atherosclerotic disease that is independent of traditional risk factors.

AB - Objective To determine if hepatocyte growth factor (HGF), a promising biomarker of coronary heart disease (CHD) given its release into circulation in response to endothelial damage, is associated with subclinical and clinical CHD in a racial/ethnic diverse population. Methods HGF was measured in 6738 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Highest mean HGF values (pg/mL) were observed in Hispanic, followed by African, non-Hispanic white, then Chinese Americans. Results In all races/ethnicities, HGF levels were associated with older age, higher systolic blood pressure (SBP) and body mass index, lower high-density lipoprotein, diabetes and current smoking. In fully adjusted models, each SD higher HGF was associated with an average increase in coronary artery calcium (CAC) of 55 Agatston units for non-Hispanic whites (p<0.001) and 51 Agatston units for African-Americans (p=0.007) but was not in the other race/ethnic groups (interaction p=0.02). There were 529 incident CHD events, and CHD risk was 41% higher in African (p<0.001), 17% in non-Hispanic white (p=0.026) and Chinese (p=0.36), and 6% in Hispanic Americans (p=0.56) per SD increase in HGF. Conclusion In a large and diverse population-based cohort, we report that HGF is associated with subclinical and incident CHD. We demonstrate evidence of racial/ethnic heterogeneity within these associations, as the results are most compelling in African-Americans and non-Hispanic white Americans. We provide evidence that HGF is a biomarker of atherosclerotic disease that is independent of traditional risk factors.

KW - atherosclerosis

KW - coronary disease

KW - epidemiology

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=85024494192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024494192&partnerID=8YFLogxK

U2 - 10.1136/heartjnl-2016-310450

DO - 10.1136/heartjnl-2016-310450

M3 - Article

C2 - 28572400

AN - SCOPUS:85024494192

VL - 103

SP - 1185

EP - 1193

JO - Heart

JF - Heart

SN - 1355-6037

IS - 15

ER -